NASDAQ:OCUP
Ocuphire Pharma, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.ocuphire.comipo date
Nov 10, 2005
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision...Show More
Earnings
Earnings Release in 13 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus